JP2019511558A5 - - Google Patents

Download PDF

Info

Publication number
JP2019511558A5
JP2019511558A5 JP2018554479A JP2018554479A JP2019511558A5 JP 2019511558 A5 JP2019511558 A5 JP 2019511558A5 JP 2018554479 A JP2018554479 A JP 2018554479A JP 2018554479 A JP2018554479 A JP 2018554479A JP 2019511558 A5 JP2019511558 A5 JP 2019511558A5
Authority
JP
Japan
Prior art keywords
patch
excipients
patches according
abaroparachido
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018554479A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019511558A (ja
JP6920341B2 (ja
Filing date
Publication date
Priority claimed from PCT/US2016/056196 external-priority patent/WO2017062922A1/en
Application filed filed Critical
Priority claimed from PCT/US2017/026462 external-priority patent/WO2017184355A1/en
Publication of JP2019511558A publication Critical patent/JP2019511558A/ja
Publication of JP2019511558A5 publication Critical patent/JP2019511558A5/ja
Priority to JP2021069599A priority Critical patent/JP6919087B2/ja
Priority to JP2021121353A priority patent/JP7139498B2/ja
Application granted granted Critical
Publication of JP6920341B2 publication Critical patent/JP6920341B2/ja
Priority to JP2022142197A priority patent/JP2022171769A/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018554479A 2016-04-18 2017-04-06 アバロパラチドの製剤、その経皮パッチ、およびその使用 Expired - Fee Related JP6920341B2 (ja)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2021069599A JP6919087B2 (ja) 2016-04-18 2021-04-16 アバロパラチドの製剤、その経皮パッチ、およびその使用
JP2021121353A JP7139498B2 (ja) 2016-04-18 2021-07-26 アバロパラチドの製剤、その経皮パッチ、およびその使用
JP2022142197A JP2022171769A (ja) 2016-04-18 2022-09-07 アバロパラチドの製剤、その経皮パッチ、およびその使用

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US201662324336P 2016-04-18 2016-04-18
US62/324,336 2016-04-18
US201662353249P 2016-06-22 2016-06-22
US62/353,249 2016-06-22
US201662396196P 2016-09-18 2016-09-18
US62/396,196 2016-09-18
PCT/US2016/056196 WO2017062922A1 (en) 2015-10-09 2016-10-08 Formulations of pthrp analogues, transdermal patches thereof, and uses thereof
USPCT/US2016/056196 2016-10-08
US201762479250P 2017-03-30 2017-03-30
US62/479,250 2017-03-30
PCT/US2017/026462 WO2017184355A1 (en) 2016-04-18 2017-04-06 Formulations of abaloparatide, transdermal patches thereof, and uses thereof

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2021069599A Division JP6919087B2 (ja) 2016-04-18 2021-04-16 アバロパラチドの製剤、その経皮パッチ、およびその使用
JP2021121353A Division JP7139498B2 (ja) 2016-04-18 2021-07-26 アバロパラチドの製剤、その経皮パッチ、およびその使用

Publications (3)

Publication Number Publication Date
JP2019511558A JP2019511558A (ja) 2019-04-25
JP2019511558A5 true JP2019511558A5 (enExample) 2020-02-13
JP6920341B2 JP6920341B2 (ja) 2021-08-18

Family

ID=60116311

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2018554479A Expired - Fee Related JP6920341B2 (ja) 2016-04-18 2017-04-06 アバロパラチドの製剤、その経皮パッチ、およびその使用
JP2021069599A Expired - Fee Related JP6919087B2 (ja) 2016-04-18 2021-04-16 アバロパラチドの製剤、その経皮パッチ、およびその使用
JP2021121353A Active JP7139498B2 (ja) 2016-04-18 2021-07-26 アバロパラチドの製剤、その経皮パッチ、およびその使用
JP2022142197A Pending JP2022171769A (ja) 2016-04-18 2022-09-07 アバロパラチドの製剤、その経皮パッチ、およびその使用

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2021069599A Expired - Fee Related JP6919087B2 (ja) 2016-04-18 2021-04-16 アバロパラチドの製剤、その経皮パッチ、およびその使用
JP2021121353A Active JP7139498B2 (ja) 2016-04-18 2021-07-26 アバロパラチドの製剤、その経皮パッチ、およびその使用
JP2022142197A Pending JP2022171769A (ja) 2016-04-18 2022-09-07 アバロパラチドの製剤、その経皮パッチ、およびその使用

Country Status (7)

Country Link
US (3) US10568937B2 (enExample)
EP (2) EP3481414B1 (enExample)
JP (4) JP6920341B2 (enExample)
AU (2) AU2017253674B2 (enExample)
CA (1) CA3020333A1 (enExample)
ES (1) ES2904891T3 (enExample)
WO (1) WO2017184355A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3020333A1 (en) 2016-04-18 2017-10-26 Radius Health, Inc. Formulations of abaloparatide, transdermal patches thereof, and uses thereof
US10996208B2 (en) * 2017-04-28 2021-05-04 Radius Health, Inc. Abaloparatide formulations and methods of testing, storing, modifying, and using same
KR20210134324A (ko) * 2019-02-28 2021-11-09 라디우스 헬쓰, 인코포레이티드 아발로파라티드의 전달을 위한 경피 시스템 및 사용 방법
CN110917243B (zh) * 2019-12-30 2021-06-04 南京晓庄学院 一种含植物提取物的凝胶膏剂及其制备方法
WO2021149012A1 (en) 2020-01-24 2021-07-29 Radius Health, Inc. Methods of stimulating bone growth with abalopartide and denosumab
WO2022149066A1 (en) * 2021-01-05 2022-07-14 Radius Health, Inc. Treatment of long bone fractures with abaloparatide
US12023156B2 (en) 2021-10-13 2024-07-02 Satio, Inc. Dermal patch for collecting a physiological sample
US11452474B1 (en) 2021-04-14 2022-09-27 Satio, Inc. Dual lever dermal patch system
US12178979B2 (en) 2021-10-13 2024-12-31 Satio, Inc. Dermal patch for delivering a pharmaceutical
US12053284B2 (en) 2021-11-08 2024-08-06 Satio, Inc. Dermal patch for collecting a physiological sample
US12214346B2 (en) 2021-10-13 2025-02-04 Satio, Inc. Dermal patch with a diagnostic test strip
US11964121B2 (en) 2021-10-13 2024-04-23 Satio, Inc. Mono dose dermal patch for pharmaceutical delivery
US11877848B2 (en) 2021-11-08 2024-01-23 Satio, Inc. Dermal patch for collecting a physiological sample
US12048543B2 (en) 2021-11-08 2024-07-30 Satio, Inc. Dermal patch for collecting a physiological sample with removable vial
WO2023281447A1 (en) 2021-07-07 2023-01-12 Radius Health, Inc. Methods of treating a cardiovascular ischemic event
WO2024246840A1 (en) * 2023-06-01 2024-12-05 Radius Health, Inc. Methods for identification and quantitation of abaloparatide and related peptide impurities
CN119113134B (zh) * 2024-09-13 2025-05-16 南京羚诺生物医药技术研究院有限公司 一种提升阿巴帕肽半衰期的制备方法及其在治疗骨质疏松症中的用途

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5589452A (en) 1992-07-14 1996-12-31 Syntex (U.S.A.) Inc. Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
CA2302255C (en) 1997-09-09 2011-11-08 F. Hoffmann-La Roche Ag Fracture healing using pthrp analogs
US20040033950A1 (en) 2000-09-26 2004-02-19 Hock Janet M. Method of increasing bone toughness and stiffness and reducing fractures
GB0017999D0 (en) 2000-07-21 2000-09-13 Smithkline Beecham Biolog Novel device
EP1333880B1 (en) 2000-10-26 2009-04-15 Alza Corporation Transdermal drug delivery devices having coated microprotrusions
ES2333849T3 (es) 2001-04-20 2010-03-02 Alza Corporation Disposicion de microsalientes que presenta un revestimiento que contiene un agente beneficioso.
US6881203B2 (en) 2001-09-05 2005-04-19 3M Innovative Properties Company Microneedle arrays and methods of manufacturing the same
EP1476178A4 (en) * 2002-02-14 2009-08-26 Bayer Pharmaceuticals Corp FORMULATION STRATEGIES IN STABILIZING PEPTIDES IN ORGANIC SOLVENTS AND DRY CONDITIONS
EP1513547A4 (en) 2002-05-23 2009-11-04 Michael F Holick USE OF PEPTIDE ANALOGUES OF PARATHYROID HORMONE FOR THE TREATMENT OF VAGINAL ATROPHY
EP1523367A1 (en) 2002-07-19 2005-04-20 3M Innovative Properties Company Microneedle devices and microneedle delivery apparatus
BRPI0412029A (pt) * 2003-06-30 2006-09-05 Alza Corp formulações para microprojeções revestidas contendo contra-ìons não-voláteis
WO2005014034A1 (en) * 2003-07-14 2005-02-17 Nps Allelix Corp. Stabilized formulation of parathyroid hormone
JP2007503268A (ja) 2003-08-25 2007-02-22 スリーエム イノベイティブ プロパティズ カンパニー 免疫応答修飾化合物の送達
JP5007427B2 (ja) 2004-05-13 2012-08-22 アルザ コーポレイション 副甲状腺ホルモン剤の経皮送達のための装置および方法
JP5015787B2 (ja) 2004-11-18 2012-08-29 スリーエム イノベイティブ プロパティズ カンパニー マイクロニードルアレイの接触コーティング法
US20070270341A1 (en) 2005-09-06 2007-11-22 Paul Morley Parathyroid hormone analogues and methods of use
JP2009522288A (ja) 2005-12-28 2009-06-11 アルザ コーポレイション 安定な治療剤形
CN101466393A (zh) 2006-03-15 2009-06-24 阿尔扎公司 用于经皮递送甲状旁腺激素药剂以治疗骨质减少的方法
US7803770B2 (en) * 2006-10-03 2010-09-28 Radius Health, Inc. Method of treating osteoporosis comprising administration of PTHrP analog
CA2664734C (en) 2006-10-03 2023-08-01 Radius Health, Inc. Method of drug delivery for bone anabolic protein
US20090016935A1 (en) * 2007-07-09 2009-01-15 Andrianov Alexander K Coating formulations including polyphosphazene polyelectrolytes and biologically active agents and asperities coated with such formulations
CN102016389B (zh) * 2008-05-16 2012-10-31 夏普株式会社 背光源单元和液晶显示装置
KR20110086854A (ko) 2008-11-18 2011-08-01 쓰리엠 이노베이티브 프로퍼티즈 컴파니 중공 마이크로니들 어레이 및 방법
JP2012523270A (ja) 2009-04-10 2012-10-04 スリーエム イノベイティブ プロパティズ カンパニー 中空マイクロニードルアレイを製造する方法並びにそれに由来する製品及びその使用法
WO2011075569A1 (en) 2009-12-18 2011-06-23 3M Innovative Properties Company Molding thermotropic liquid crystalline polymers and articles made therefrom
KR101728194B1 (ko) 2010-02-24 2017-05-02 히사미쓰 세이야꾸 가부시키가이샤 마이크로 니들 디바이스 및 그 제조 방법
US8637458B2 (en) 2010-05-12 2014-01-28 Biodel Inc. Insulin with a stable basal release profile
WO2012119004A2 (en) * 2011-03-01 2012-09-07 Sloan-Kettering Institute For Cancer Research Parathyroid hormone analogs, compositions and uses thereof
SG194570A1 (en) * 2011-04-22 2013-12-30 Radius Health Inc Method of drug delivery for pth, pthrp and related peptides
AU2012345768B2 (en) * 2011-11-30 2016-05-12 Kindeva Drug Delivery L.P. Microneedle device having a peptide therapeutic agent and an amino acid, methods of making and using the same
US9581438B2 (en) 2012-12-31 2017-02-28 General Electric Company Systems and methods for control of a non-destructive testing system
KR101866005B1 (ko) 2013-02-13 2018-06-08 히사미쓰 세이야꾸 가부시키가이샤 마이크로 니들 코팅용 조성물 및 마이크로 니들 디바이스
CN105555353B (zh) 2013-09-18 2019-01-01 考司美德制药株式会社 一种微针贴应用装置以及一种贴支架
ES2630106T3 (es) * 2014-10-07 2017-08-18 Cyprumed Gmbh Formulaciones farmacéuticas para la administración oral de fármacos peptídicos o proteicos
WO2016141250A1 (en) 2015-03-03 2016-09-09 Radius Health, Inc. USES OF PTHrP ANALOGUE IN REDUCING FRACTURE RISK
JP2018529749A (ja) 2015-10-07 2018-10-11 シプルメット・ゲーエムベーハー ペプチド薬物を経口送達するための医薬製剤
BR112018007159A2 (pt) 2015-10-09 2018-11-06 3M Innovative Properties Co formulações de análogos de pthrp, emplastros transdérmicos dos mesmos e usos dos mesmos
ES2909043T3 (es) 2015-10-09 2022-05-05 Kindeva Drug Delivery Lp Composiciones de zinc para sistemas de microagujas recubiertos
CA3020333A1 (en) 2016-04-18 2017-10-26 Radius Health, Inc. Formulations of abaloparatide, transdermal patches thereof, and uses thereof

Similar Documents

Publication Publication Date Title
MY187047A (en) Selective pyy compounds and uses thereof
MX393855B (es) Terapia de combinación que comprende un inhibidor de raf y trametinib
CY1119007T1 (el) Συνθεσεις και μεθοδοι αγωγης πνευμονικης υπερτασης
CY1123627T1 (el) Παραγωγα διυδροϊμιδαζοπυραζινονης χρησιμα στη θεραπευτικη αντιμετωπιση του καρκινου
MX383665B (es) Composiciones de donepezilo y métodos para tratar la enfermedad de alzheimer.
WO2015009991A3 (en) Methods, systems, and compositions for promoting bone growth
TN2017000467A1 (en) Amido-substituted cyclohexane derivatives
JOP20200315B1 (ar) مركبات بورينون واستخدامها في معالجة السرطان
HRP20211127T1 (hr) Formulacije analoga pthrp, njihovi transdermalni flasteri, i njihova uporaba
PH12019502150A1 (en) Compounds and methods for the treatment of parasitic diseases
MX2016012574A (es) Compuestos heteroarilo sustituidos y metodos de uso.
CY1118947T1 (el) Ασυμμετρες ουριες και ιατρικες χρησεις αυτων
WO2017037594A3 (zh) 用于减少局部脂肪的医药组成物及其用途
EA201691490A1 (ru) Фармацевтическая композиция, содержащая бринзоламид
MX2020012336A (es) Formulacion farmaceutica.
PH12015501945B1 (en) Formulations of organic compounds
EA201692111A1 (ru) Фармацевтические композиции, содержащие данириксин, для лечения инфекционных заболеваний
WO2016140933A3 (en) Immediate release soluble ibuprofen compositions
WO2015081319A3 (en) Activity enhancing curcumin compositions and methods of use
ES2948324R1 (es) Proceso para preparar (15alfa,16alfa,17beta)-estra-1,3,5(10)-trieno-3,15,16,17-tetrol monohidrato (Estetrol monohidrato)
WO2016004413A3 (en) Gls1 inhibitors for treating disease
EA201790383A1 (ru) Композиции и способы лечения и профилактики инфекций области хирургического вмешательства
JOP20190086A1 (ar) مشتقات نافثيريدينون جديدة واستخدامها في معالجة عدم انتظام ضربات القلب
UA118474C2 (uk) (s)-пірліндол та його фармацевтично прийнятні солі для застосування в медицині
CY1125075T1 (el) Εκχυλισμα salvia haenkei σαν δραστικος παραγοντας στις διαδικασιες επανεπιθηλιωσης και επουλωσης ιστων